Article
Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative.
Translational research : the journal of laboratory and clinical medicine - 1 May 2017
Wei Jun, Zhu Hongyan, Lord Gabriel, Bhattachayya Mitra, Jones Brielle M, Allaway Graham, Biswal Shyam S, Korman Benjamin, Marangoni Roberta G, Tourtellotte Warren G, Varga John
Abstract excerpt
The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) governs antioxidant, innate immune and cytoprotective responses and its deregulation is prominent in chronic inflammatory conditions. To examine the hypothesis that Nrf2 might be implicated in systemic sclerosis (SSc), we investigated its expression, activity, and mechanism of action in SSc patient samples and mouse models of fibrosis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
